Top

Acta Neurochirurgica

Published in:

01-11-2015 | Letter to the editor - Brain Tumors

Successful treatment of recurrent preoperative bleeding of glioblastoma with recombinant activated factor VII: pathophysiological hypothesis

Authors: Baptiste Duceau, Stephane Welschbillig, Nicolas Engrand, Anne Godier

Published in: Acta Neurochirurgica | Issue 11/2015

Excerpt

Dear Editor, …

Drake TA, Morrissey JH, Edgington TS (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134(5):1087–1097PubMedCentralPubMed

Felfernig M, Huepfl M (2008) Experience of recombinant activated factor VII (NovoSeven) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients. Clin Neurol Neurosurg 110(3):227–232CrossRefPubMed

Hartmann M, Sucker C, Messing M (2006) Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature. J Neurosurg 104(1 Suppl):55–58PubMed

Heisel M, Nagib M, Madsen L, Alshiekh M, Bendel A (2004) Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients. Pediatr Blood Cancer 43(6):703–705CrossRefPubMed

Kapapa T, König K, Heissler HE, Schatzmann C, Tschan CA, Perl M, von Depka M, Zumkeller M, Rickels E (2009) The use of recombinant activated factor VII in neurosurgery. Surg Neurol 71(2):172–179, discussion 179CrossRefPubMed

Karadimov D, Binev K, Nachkov Y, Platikanov V (2003) Use of activated recombinant Factor VII (NovoSeven) during neurosurgery. J Neurosurg Anesthesiol 15(4):330–332CrossRefPubMed

Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, FAST Trial Investigators (2008) Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358(20):2127–2137CrossRefPubMed

McLendon R, Rosenblum M, Bigne D (2006) Russell & Rubinstein’s Pathology of Tumors of the Nervous System

Takeshima H, Nishi T, Kuratsu J, Kamikubo Y, Kochi M, Ushio Y (2000) Suppression of the tissue factor-dependent coagulation cascade: a contributing factor for the development of intratumoral hemorrhage in glioblastoma. Int J Mol Med 6(3):271–276PubMed

10.

Uhrig L, Blanot S, Baugnon T, Orliaguet G, Carli PA, Meyer PG (2007) Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc 8(6):576–579

Title: Successful treatment of recurrent preoperative bleeding of glioblastoma with recombinant activated factor VII: pathophysiological hypothesis
Authors: Baptiste Duceau
Stephane Welschbillig
Nicolas Engrand
Anne Godier
Publication date: 01-11-2015
Publisher: Springer Vienna
Published in: Acta Neurochirurgica / Issue 11/2015
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-015-2577-3

At a glance: The STEP trials

Springer Medicine

Successful treatment of recurrent preoperative bleeding of glioblastoma with recombinant activated factor VII: pathophysiological hypothesis

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2015

Bony surface registration of navigation system in the lateral or prone position: technical note

A review of spontaneous intracranial extradural hematoma in sickle-cell disease

Contemporary frameless intracranial biopsy techniques: Might variation in safety and efficacy be expected?

Hyperperfusion syndrome after aneurysm surgery: a case report

Management of vessels passing through the facial nerve in the treatment of hemifacial spasm

Poor diagnostic accuracy of transcranial motor and somatosensory evoked potential monitoring during brainstem cavernoma resection